Regeneron has halted high dose treatment of a Phase III osteoarthritis drug following a risk-benefit assessment conducted by an Independent Data Monitoring Committee.
biospace.com
The knee joint is the most common site of osteoarthritis. While joint replacement is considered an ultimate solution, radiofrequency denervation may be contemplated in some cases. Radiofrequency ablation requires precise localization of the articular branches innervating the joint capsule. The objec…
insights.ovid.com
Cooled Radiofrequency Ablation Is Significantly More Effective Than Intra-articular Steroid Injection for Managing Pain and Physical Function in Patients With Osteoarthritis-Related Knee Pain
dgnews.docguide.co